Most lately, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in comparable spots as classical opioid receptors, it binds to some wide array of endogenous opioids. Contrary to most opioid receptors, this receptor functions being a scavenger and doesn't acti